Get started
Author

Megha Garg

A randomized, double-blind, placebo-controlled trial of infliximab in refractory polymyositis and dermatomyositis
2017 · Adam Schiffenbauer, Megha Garg, et al. · Seminars in Arthritis and Rheumatism · 72
Deficiency of Interleukin-1 Receptor Antagonist (DIRA): Report of the First Indian Patient and a Novel Deletion Affecting IL1RN
2017 · Leonardo O. Mendonca, Louise Malle, et al. · Journal of Clinical Immunology · 56
Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist
2017 · Megha Garg, Adriana A. de Jesus, et al. · JCI Insight · 55
PDF
Recommendations and barriers to vaccination in systemic lupus erythematosus
2018 · Megha Garg, Naaima Mufti, et al. · Autoimmunity Reviews · 40
Developmental Heterogeneity in DNA Packaging Patterns Influences T-Cell Activation and Transmigration
2012 · Soumya Gupta, Nimi Marcel, et al. · PLoS ONE · 19
PDF
The Linker Histone H1.2 Is an Intermediate in the Apoptotic Response to Cytokine Deprivation in T-Effectors
2014 · Megha Garg, Lakshmi R. Perumalsamy, et al. · International Journal of Cell Biology · 10
PDF
Apoptotic Programs Are Determined during Lineage Commitment of CD4+ T Effectors: Selective Regulation of T Effector-Memory Apoptosis by Inducible Nitric Oxide Synthase
2012 · Divya Purushothaman, Nimi Marcel, et al. · The Journal of Immunology · 5
Deficiency of the IL-1 Receptor Antagonist (DIRA)
2018 · Megha Garg, Adriana A. de Jesus · Springer eBooks · 1
Deficiency of the IL-1 Receptor Antagonist (DIRA)
2020 · Megha Garg, Adriana A. de Jesus · Springer eBooks
Works count: 9
Citation count: 258
H-index: 6
I10-index: 6
Year
Topic
Type